Structure of a bacterial homologue of vitamin K epoxide reductase

Nature

Volumn 463, Issue 7280, 2010, Pages 507-512

  Li, Weikai ^a   Schulman, Sol ^a   Dutton, Rachel J ^b   Boyd, Dana ^b   Beckwith, Jon ^b   Rapoport, Tom A ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CYSTEINE; METHIONINE; QUINONE DERIVATIVE; THIOREDOXIN; UNCLASSIFIED DRUG; VITAMIN K EPOXIDE REDUCTASE; VITAMIN K GROUP; WARFARIN;

BACTERIUM; BLOOD; ELECTRON; ENZYME ACTIVITY; INHIBITOR; MICROBIAL ACTIVITY; MUTATION; VITAMIN;

ARTICLE; CATALYSIS; CRYSTAL STRUCTURE; DISULFIDE BOND; ELECTRON TRANSPORT; ENZYME STRUCTURE; ESCHERICHIA COLI; MUTATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SYNECHOCOCCUS;

ANIMALS; ANTICOAGULANTS; BACTERIAL PROTEINS; CATALYTIC DOMAIN; DISULFIDES; DRUG RESISTANCE; ELECTRON TRANSPORT; HUMANS; MEMBRANE PROTEINS; MIXED FUNCTION OXYGENASES; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; SYNECHOCOCCUS; WARFARIN;

BACTERIA (MICROORGANISMS); MAMMALIA; SYNECHOCOCCUS SP.;

EID: 75749153714     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08720     Document Type: Article

References (43)

1. Oldenburg, J., Marinova, M., Muller-Reible, C. & Watzka, M. The vitamin K cycle. Vitam. Horm. 78, 35-62 (2008).
2. Tie, J. K. & Stafford, D. W. Structure and function of vitamin K epoxide reductase. Vitam. Horm. 78, 103-130 (2008).
3. Stenflo, J. & Suttie, J. W. Vitamin K-dependent formation of c-carboxyglutamic acid. Annu. Rev. Biochem. 46, 157-172 (1977).
4. Furie, B., Bouchard, B. A. & Furie, B. C. Vitamin K-dependent biosynthesis of c-carboxyglutamic acid. Blood 93, 1798-1808 (1999).
5. Wajih, N., Hutson, S. M. & Wallin, R. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction. J. Biol. Chem. 282, 2626-2635 (2007).
6. Soute, B. A., Groenen-van Dooren, M. M., Holmgren, A., Lundstrom, J. & Vermeer, C. Stimulation of the dithiol-dependent reductases in the vitamin K cycle by the thioredoxin system. Strong synergistic effects with protein disulphide-isomerase. Biochem. J. 281, 255-259 (1992).
7. Chu, P. H., Huang, T. Y., Williams, J. & Stafford, D. W. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Proc. Natl Acad. Sci. USA 103, 19308-19313 (2006)
8. The International Warfarin Pharmacogenetics Consortium. Estimationof thewarfarin dose with clinical and pharmacogenetic data. N. Engl. J. Med. 360, 753-764 (2009).
9. Rost, S. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427, 537-541 (2004).
10. Goodstadt, L. & Ponting, C. P. Vitamin K epoxide reductase: homology, active site and catalytic mechanism. Trends Biochem. Sci. 29, 289-292 (2004).
11. Singh, A. K., Bhattacharyya-Pakrasi, M. & Pakrasi, H. B. Identification of an atypical membrane protein involved in the formation of protein disulfide bonds in oxygenic photosynthetic organisms. J. Biol. Chem. 283, 15762-15770 (2008).
12. Dutton, R. J., Boyd, D., Berkmen, M. & Beckwith, J. Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation. Proc. Natl Acad. Sci. USA 105, 11933-11938 (2008).
13. Inaba, K. et al. DsbB elicits a red-shift of bound ubiquinone during the catalysis of DsbA oxidation. J. Biol. Chem. 279, 6761-6768 (2004).
14. Inaba, K. et al. Crystal structure of the DsbB-DsbA complex reveals a mechanism of disulfide bond generation. Cell 127, 789-801 (2006).
15. Dutton, R. J. et al. Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin. Proc. Natl Acad. Sci. USA advance online publication, doi:10.1073/pnas.0912952107 (15 December 2009).
16. Tie, J. K., Nicchitta, C., von Heijne, G. & Stafford, D. W. Membrane topology mapping of vitamin K epoxide reductase by in vitro translation/ cotranslocation. J. Biol. Chem. 280, 16410-16416 (2005).
17. Rost, S. et al. Novel mutations in the VKORC1 gene of wild rats and mice-a response to 50 years of selection pressure by warfarin? BMC Genet. 10, 4 (2009).
18. Pelz, H. J. et al. The genetic basis of resistance to anticoagulants in rodents. Genetics 170, 1839-1847 (2005).
19. Rost, S. et al. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin. Thromb. Haemost. 94, 780-786 (2005).
20. D'Ambrosio, R. L., D'Andrea, G., Cafolla, A., Faillace, F. & Margaglione, M. A new vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with decreased stability of CYP2C9 enzyme. J. Thromb. Haemost. 5, 191-193 (2007).
21. Silverman, R. B. Chemical model studies for the mechanism of vitamin K epoxide reductase. J. Am. Chem. Soc. 103, 5939-5941 (1981).
22. Gross, E., Kastner, D. B., Kaiser, C. A. & Fass, D. Structure of Ero1p, source of disulfide bonds for oxidative protein folding in the cell. Cell 117, 601-610 (2004).
23. Gross, E., Sevier, C. S., Vala, A., Kaiser, C. A. & Fass, D. A new FAD-binding fold and intersubunit disulfide shuttle in the thiol oxidase Erv2p. Nature Struct. Biol. 9, 61-67 (2002).
24. Gebauer, M. Synthesis and structure-activity relationships of novel warfarin derivatives. Bioorg. Med. Chem. 15, 2414-2420 (2007).
25. Jin, D. Y., Tie, J. K. & Stafford, D. W. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines. Biochemistry 46, 7279-7283 (2007).
26. Bardwell, J. C. et al. A pathway for disulfide bond formation in vivo. Proc. Natl Acad. Sci. USA 90, 1038-1042 (1993).
27. Bader, M., Muse, W., Zander, T. & Bardwell, J. Reconstitution of a protein disulfide catalytic system. J. Biol. Chem. 273, 10302-10307 (1998).
28. Kishigami, S., Kanaya, E., Kikuchi, M. & Ito, K. DsbA-DsbB interaction through their active site cysteines. Evidence from an odd cysteine mutant of DsbA. J. Biol. Chem. 270, 17072-17074 (1995).
29. Malojcic, G., Owen, R. L., Grimshaw, J. P. & Glockshuber, R. Preparation and structure of the charge-transfer intermediate of the transmembrane redox catalyst DsbB. FEBS Lett. 582, 3301-3307 (2008).
30. Zhou, Y. et al. NMR solution structure of the integral membrane enzyme DsbB: functional insights into DsbB-catalyzed disulfide bond formation. Mol. Cell 31, 896-908 (2008).
31. Inaba, K. et al. Dynamic nature of disulphide bond formation catalysts revealed by crystal structures of DsbB. EMBO J. 28, 779-791 (2009).
32. Regeimbal, J. et al. Disulfide bond formation involves a quinhydrone-type charge-transfer complex. Proc. Natl Acad. Sci. USA 100, 13779-13784 (2003).
33. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
34. Terwilliger, T. C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D 55, 849-861 (1999).
35. Cowtan, K. D. & Main, P. Phase combination and cross validation in iterated density-modification calculations. Acta Crystallogr. D 52, 43-48 (1996).
36. Zhang, K. Y., Cowtan, K. & Main, P. Combining constraints for electron-density modification. Methods Enzymol. 277, 53-64 (1997).
37. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. A 64, 112-122 (2008).
38. Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nature Protocols 3, 1171-1179 (2008).
39. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
40. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
41. Winn, M. D., Isupov, M. N. & Murshudov, G. N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D 57, 122-133 (2001).
42. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
43. Tu, B. P., Ho-Schleyer, S. C., Travers, K. J. & Weissman, J. S. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science 290, 1571-1574 (2000).